ERBB/EGFR signalling pathway defects are associated with cancers, and it is known that depletion or inhibition of ADAM17, a sheddase that releases ERBB ligands from the plasma membrane, can suppress KRAS-induced lung tumour growth. Matthew Freeman’s group studies iRhoms, rhomboid-like proteins that regulate ADAM17. Here (Sieber, Lu et al., 2022), they demonstrate that iRhom2 is required for the increased shedding of ERBB ligands observed in HEK293T cells expressing oncogenic KRAS. Delving into the underlying mechanism, they find that oncogenic KRAS induces phosphorylation of cytoplasmic domain of iRhom2 via the Raf/MEK/ERK pathway. This phosphorylation step is essential for amplified ERBB shedding, given that it allows iRhom2 to recruit 14-3-3ε, a process known to be sufficient for ADAM17 activation. This mechanism is conserved in A549 cells, a model for human lung adenocarcinoma. Knocking out iRhom1 and iRhom2 using CRISPR/Cas9 in A549 cells decreased proliferation and, when these cells were injected into immunodeficient mice, there was no detectable tumour growth. Importantly, cancer-associated iRhom2 mutations promote an increase in both ERBB shedding and the growth in vitro of tumour-like ‘spheroids’ when compared with wild-type iRhom2 A549 cells, and this amplified ERBB signalling sustains KRAS activity. This work therefore identifies iRhom2 as a key player in a positive feedback loop that contributes to lung tumorigenesis.
Shedding light on the role of iRhom2 in cancer
- Split-screen
- Views Icon Views
-
Article Versions Icon
Versions
- Version of Record 14 September 2022
- Share Icon Share
-
Tools Icon
Tools
- Search Site
Shedding light on the role of iRhom2 in cancer. J Cell Sci 1 September 2022; 135 (17): e135_e1702. doi:
Download citation file:
Advertisement
Cited by
Imaging Cell Architecture and Dynamics

We are now welcoming submissions for our upcoming Special Issue: Imaging Cell Architecture and Dynamics. This issue will be coordinated by two Guest Editors: Lucy Collinson (The Francis Crick Institute, UK) and Guillaume Jacquemet (University of Turku, Finland). Submission deadline: 1 March 2024.
2024 Journal Meeting 'Diversity and Evolution in Cell Biology'

Registration is open for our 2024 Journal Meeting Diversity and Evolution in Cell Biology, which aims to bring together evolutionary biologists and cell biologists investigating diverse aspects of cellular physiology. Early-bird deadline is 19 January 2024.
Become a FocalPlane correspondent

FocalPlane, our community site for microscopists, is looking to appoint three scientists as correspondents who will play a key role in developing and writing content over the coming year. Interested? Find out how to become a FocalPlane correspondent here.
Sustainable Conferencing Initiative

Through our Sustainable Conferencing Grants, we promote the use of new technology and greener modes of travel. Our blog posts showcase examples of sustainability in action and share experience about how new technologies and conference formats work in practice.
Reasons to submit to Journal of Cell Science

There are many benefits to publishing in Journal of Cell Science - read more about why you should choose JCS or visit our submission page now.